Report cover image

Global Tuberculosis Vaccines Market Growth 2025-2031

Published Oct 14, 2025
Length 95 Pages
SKU # LPI20469082

Description

The global Tuberculosis Vaccines market size is predicted to grow from US$ 78.5 million in 2025 to US$ 93.5 million in 2031; it is expected to grow at a CAGR of 2.9% from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Tuberculosis (TB) is an infectious disease which is caused by the bacteria called Mycobacterium tuberculosis (MTB). Tuberculosis mainly affects lungs, but can also affect other parts of the body. Typical signs of tuberculosis includes chronic or persistent cough and sputum production. When TB is at an advanced stage the sputum will contain blood and other symptoms include lack of appetite, weight loss, fever, and night sweats.

United States market for Tuberculosis Vaccines is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Tuberculosis Vaccines is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Tuberculosis Vaccines is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Tuberculosis Vaccines players cover Sanofi, Merck, Serum Institute of India, GlaxoSmithKline, Japan BCG Lab, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Tuberculosis Vaccines Industry Forecast” looks at past sales and reviews total world Tuberculosis Vaccines sales in 2024, providing a comprehensive analysis by region and market sector of projected Tuberculosis Vaccines sales for 2025 through 2031. With Tuberculosis Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tuberculosis Vaccines industry.

This Insight Report provides a comprehensive analysis of the global Tuberculosis Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Tuberculosis Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Tuberculosis Vaccines market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tuberculosis Vaccines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tuberculosis Vaccines.

This report presents a comprehensive overview, market shares, and growth opportunities of Tuberculosis Vaccines market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Immunotherapeutic Vaccines
Booster Vaccines
Others

Segmentation by Application:
Hospitals
Clinics
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Sanofi
Merck
Serum Institute of India
GlaxoSmithKline
Japan BCG Lab
IDT Biologics
GreenSignal Bio Pharma
Taj Pharmaceuticals
Bavarian Nordic
China National Biotec Group

Key Questions Addressed in this Report

What is the 10-year outlook for the global Tuberculosis Vaccines market?

What factors are driving Tuberculosis Vaccines market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Tuberculosis Vaccines market opportunities vary by end market size?

How does Tuberculosis Vaccines break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.

Table of Contents

95 Pages
*This is a tentative TOC and the final deliverable is subject to change.*
1 Scope of the Report
2 Executive Summary
3 Global by Company
4 World Historic Review for Tuberculosis Vaccines by Geographic Region
5 Americas
6 APAC
7 Europe
8 Middle East & Africa
9 Market Drivers, Challenges and Trends
10 Manufacturing Cost Structure Analysis
11 Marketing, Distributors and Customer
12 World Forecast Review for Tuberculosis Vaccines by Geographic Region
13 Key Players Analysis
14 Research Findings and Conclusion
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.